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abstract

BACKGROUND: Neurodevelopmental disability is the most common complication for survivors of surgery
for congenital heart disease (CHD).
METHODS: We analyzed individual participant data from studies of children evaluated with the Bayley Scales of

Infant Development, second edition, after cardiac surgery between 1996 and 2009. The primary outcome was
Psychomotor Development Index (PDI), and the secondary outcome was Mental Development Index (MDI).
RESULTS: Among 1770 subjects from 22 institutions, assessed at age 14.5 6 3.7 months, PDIs and
MDIs (77.6 6 18.8 and 88.2 6 16.7, respectively) were lower than normative means (each P , .001).
Later calendar year of birth was associated with an increased proportion of high-risk infants
(complexity of CHD and prevalence of genetic/extracardiac anomalies). After adjustment for center
and type of CHD, later year of birth was not signiﬁcantly associated with better PDI or MDI. Risk factors
for lower PDI were lower birth weight, white race, and presence of a genetic/extracardiac anomaly
(all P # .01). After adjustment for these factors, PDIs improved over time (0.39 points/year, 95%
conﬁdence interval 0.01 to 0.78; P = .045). Risk factors for lower MDI were lower birth weight,
male gender, less maternal education, and presence of a genetic/extracardiac anomaly (all P , .001).
After adjustment for these factors, MDIs improved over time (0.38 points/year, 95% conﬁdence interval
0.05 to 0.71; P = .02).
CONCLUSIONS: Early neurodevelopmental outcomes for survivors of cardiac surgery in infancy have improved

modestly over time, but only after adjustment for innate patient risk factors. As more high-risk CHD infants
undergo cardiac surgery and survive, a growing population will require signiﬁcant societal resources.

WHAT’S KNOWN ON THIS SUBJECT:
Neurodevelopmental disabilities are the most
common, and potentially the most damaging,
sequelae of congenital heart defects. Children with
congenital heart defects undergoing surgery in
infancy have problems with reasoning, learning,
executive function, inattention and impulsive
behavior, language skills, and social skills.
WHAT THIS STUDY ADDS: Early
neurodevelopmental outcomes for survivors of
cardiac surgery in infancy have improved modestly
over time, but only after adjustment for innate patient
risk factors. As more high-risk infants with congenital
heart defects survive cardiac surgery, a growing
population will require signiﬁcant societal resources.
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Neurodevelopmental disabilities are
the most common, and potentially the
most damaging, sequelae of
complicated childhood diseases.
Although many studies have
evaluated the cognitive and
behavioral status of children who
were born prematurely, few have
been performed in children suffering
from rare conditions including
complex congenital heart disease
(CHD).1 Small studies at individual
institutions have shown that children
with CHD undergoing surgery in
infancy have more problems with
reasoning, learning, executive
function, inattention and impulsive
behavior, language skills, and social
skills compared with peers without
CHD.2–5 Lower abilities in these areas
may lead to poor school performance,
strained interpersonal relationships,
and behavior problems. Survivors of
cardiac surgery in infancy are more
likely than the general population to
require remedial services, including
tutoring and special education, as
well as physical, occupational, and
speech therapy.2,6 As these children
reach adulthood, neurodevelopmental
disabilities can limit educational
achievements, employability,
insurability, and quality of life.
Currently known risk factors explain
only ∼30% of the observed variation
in neurodevelopmental outcome after
cardiac surgery in infancy.7
Importantly, these studies have
identiﬁed few modiﬁable risk factors
for adverse neurodevelopmental
outcomes.7–9 In addition, these
studies usually derive from single
centers and are limited by small
sample size.
Many centers caring for children with
CHD have measured and reported
neurodevelopmental outcomes, often
using standardized instruments and
collecting similar data on potential
covariates and confounders. The use
of individual participant data from
multiple studies has been
championed as the gold standard for
synthesizing prognostic risk factors in
clinical prediction models.10–12
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Nevertheless, no studies using this
approach have been performed in
children with CHD or have evaluated
neurodevelopmental outcomes. In
this study, we pooled and analyzed
such data from earlier studies to
describe neurodevelopmental
outcomes of infants after open
cardiac surgery with regard to
temporal trends over a 14-year
interval.

METHODS
Identiﬁcation of Participating
Institutions
Participating institutions were
selected based on a literature search
to identify studies reporting
neurodevelopmental outcomes after
cardiac surgery in infancy
(Supplemental Table 4). The inclusion
criteria were (1) cardiac surgery
using cardiopulmonary bypass at age
#9 months; (2) enrollment in
a clinical trial or observational cohort
study with date of surgery between
January 1, 1988, and December 31,
2009; (3) neurodevelopmental
evaluation between 6 and 30 months
of age using the Bayley Scales of
Infant Development, ﬁrst edition
(BSID-I), BSID-II, or the Bayley Scales
of Infant and Toddler Development,
third edition13,14; and (4) data
available on patient and operative
management variables. Children
treated with a primary strategy of
cardiac transplantation were not
eligible. Investigators identiﬁed by
the initial literature search were
contacted and invited to participate.
Additional centers with eligible
subjects but previously unpublished
data were identiﬁed and invited to
contribute. All invited investigators
agreed to submit data for this
analysis.8,9,15–24

Preparation of the Analysis Data Set
Participating institutions reviewed
their databases to select appropriate
subjects for analysis. Each institution
obtained approval or exemption from
their institutional review board.

Center investigators submitted
a limited, deidentiﬁed standardized
dataset, including
neurodevelopmental outcome
measures and demographic,
preoperative, perioperative, and
postoperative variables
(Supplemental Table 5). Investigators
were asked to code their subjects
according to cardiac diagnosis into 1
of 4 previously described categories
that have been shown to predict
perioperative mortality: Class I, 2
ventricles with no aortic arch
obstruction; Class II, 2 ventricles with
aortic arch obstruction; Class III,
single ventricle without arch
obstruction; and Class IV, single
ventricle with arch obstruction.25
Subjects with d-transposition of the
great arteries (TGA) or tetralogy of
Fallot (TOF) are generally in Class I,
whereas subjects with hypoplastic
left heart syndrome (HLHS) are in
Class IV. Subgroup analyses were
performed based on 3 common types
of CHD: TGA with intact ventricular
septum (IVS) or ventricular septal
defect (VSD) (Class I only), TOF with
or without pulmonary atresia (PA),
and HLHS. Anomalies were classiﬁed
as deﬁnite genetic anomalies,
suspected genetic anomalies or major
extracardiac anomalies, or absent
(normal). Subjects in whom the
presence or absence of an anomaly
had not been speciﬁcally noted were
classiﬁed as being normal.
The sample was restricted to subjects
assessed using BSID-II, which was the
most commonly used instrument.
Although the sample would have
been larger had other versions of the
Bayley scales been included, no
standardized methodology exists by
which scores from different versions
of the Bayley scales can be combined.
BSID-II offers a standardized
assessment of cognitive and motor
development for children aged 1
through 42 months. It yields 2 scores:
the Psychomotor Development Index
(PDI) and the Mental Development
Index (MDI). The PDI assesses control
of gross muscle function, including
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crawling and walking, as well as ﬁne
muscle skills necessary for
prehension, use of writing
instruments, and imitation of hand
movements. The MDI assesses
memory, problem solving, early
number concepts, generalization,
vocalizations, and language and social
skills. The mean 6 SD is 100 6 15 in
the normative population for both
scores. Motor skills (PDI) are usually
more severely affected in infant
survivors of cardiac surgery than are
cognitive abilities (MDI).15,21

Dataset Preparation and Statistical
Analysis
Center investigators reviewed their
data for deidentiﬁcation, data
accuracy, data completeness, and
outlying observations before
submission to the Data Coordination
Center (DCC) at Boston Children’s
Hospital. The DCC performed
a standardized integrity examination
of the data to identify inconsistencies,
missing data, and outliers across
institutions. Communications were
exchanged with centers until all
issues were resolved. Collaborative
decisions between the lead
investigators (Drs Gaynor and
Newburger) were made with respect
to group assignment for cardiac class,
cardiac diagnosis, race, and genetic
anomaly when collapsing across
categories of a variable or handling
unique cases. Analyses included only
data for which all queries had been
resolved. The DCC merged the data
across institutions into a ﬁnal
analysis data set.
Group differences by cardiac class
were assessed by using x2 tests for
categorical variables and analysis of
variance or Kruskal–Wallis tests for
continuous variables. Comparisons of
PDI and MDI with normative means
were made using 1-sample t tests.
Primary analyses examined the
relationships of PDI and MDI from
BSID-II with year of birth. Pearson
correlations were used to examine
these relationships in the full cohort
as well as in homogeneous diagnostic
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subgroups (ie, TGA, TOF, and HLHS).
The types of CHD included in clinical
studies changed over time. Therefore,
linear regression analyses using
continuous year of birth and
adjusting for center and cardiac class
served as foundation models for
predicting PDI and MDI. Candidate
predictors in multivariable analyses
were preoperative measures and
patient factors, including birth
weight, gestational age, race, ethnicity
(Hispanic versus not Hispanic),
gender, maternal education, genetic
or extracardiac anomalies, prenatal
diagnosis, preoperative mechanical
ventilation, and neonatal status (age
at ﬁrst surgery #30 days). Factors
relating to operative management or
postoperative course were not
included. Predictors were screened to
identify associations with
a neurodevelopmental score at the
P , .25 level after adjusting for
center, cardiac class, and year of birth.
Predictors meeting this criterion were
included in stepwise backward
analysis in which P , .05 served as
the criterion for retention into the full
model. Center, cardiac class, and year
of birth were retained in all models
regardless of P value. Standardized
mean scores present the predicted
PDIs and MDIs adjusting for center,
cardiac class, and other statistically
signiﬁcant predictors at the mean
value of the covariates. Analyses were
performed using SAS 9.3 (SAS
Institute, Cary, NC).

RESULTS
Of the 2501 subjects submitted from
26 institutions in 6 countries, 1770
subjects born between 1996 and
2009 from 22 institutions were
evaluated with BSID-II and form the
cohort for this report. The cohort was
predominantly male (61.5%), white
(84.0%), and non-Hispanic (92.3%).
Cardiac diagnoses and preoperative
characteristics are shown in Table 1
for the overall cohort and each class
of CHD. Because of changes in
eligibility criteria across studies, the

majority of subjects in the early years
were in Class I, whereas in later years,
the percentage of subjects in Class IV
surpassed that in Class I (Fig 1A). The
most common cardiac defects were
HLHS (n = 549, 31.0%), followed by
TGA with IVS (n = 235, 13.3%), other
single ventricle (n = 203, 11.5%), TOF
without PA (n = 166, 9.4%), VSD (n =
148, 8.4%), and TGA with VSD (n =
121, 6.8%). Figure 1B shows
variation over time in the percentage
of subjects with a deﬁnite or
suspected genetic or major
extracardiac anomaly.
Subjects were assessed at age 14.5 6
3.7 months. Compared with
normative means, CHD subjects had
signiﬁcantly lower PDIs (77.6 6 18.8)
and MDIs (88.2 6 16.7) (each P ,
.001). PDIs and MDIs were $1 SD
below the population mean for
63.5% and 36.1% of subjects,
respectively, and $2 SD below the
mean for 36.8% and 15.3% of
subjects. Higher cardiac class,
reﬂecting more serious heart disease,
was signiﬁcantly associated with lower
PDI, but not with lower MDI (Table 1).

Univariate analyses
For the entire cohort, later year of
birth was not associated with better
PDI or MDI. Over the study period,
unadjusted mean PDIs declined (r =
20.17, P , .001), as did unadjusted
MDIs (r = 20.05, P = .03). Similarly, in
diagnostic subgroup analysis (TGA
with IVS or VSD [Class I only], TOF
with or without PA, and HLHS),
unadjusted scores did not improve
over time in any subgroup. PDIs
declined over time for subjects with
TGA (r = 20.18, P = .001) and TOF
(r = 20.16, P = .03) but were stable for
subjects with HLHS (r = 0.03, P = .44).
MDIs decreased for the TOF group
(r = 20.16, P = .03) but did not change
signiﬁcantly over time among those
with TGA or HLHS (TGA: r = 20.02,
P = .68; HLHS: r = 0.005, P = .91).

Multivariable analyses
Multivariable analyses adjusting for
center, cardiac class, and year of birth

GAYNOR et al

TABLE 1 Demographic and Preoperative Characteristics and Neurodevelopmental Outcomes by Cardiac Class
Variable
Demographic and preoperative characteristics
Cardiac diagnosis
TGA/IVS
TGA/VSD
TOF
TOF/PA
TAPVC
VSD without IAA/coarctation
VSD with IAA/coarctation
AVC defects
HLHS
Other functional single ventricle anomaly
Other
Birth weight (kg)
Gestational age (wk)
Race
White
Black
Other
Hispanic ethnicity
Female gender
Maternal education
Graduate school
Completed college
High school and/or some college
Less than high school
Missing or not speciﬁed
Genetic anomaly
Normal or not speciﬁed
Suspected genetic or major extracardiac
Deﬁnite genetic
Prenatal diagnosis
Preoperative mechanical ventilation
Neonate (age #30 d) at time of surgery
Neurodevelopmental outcomes
Age at assessment (mo)
BSID-II
PDI
#85
#70
MDI
#85
#70

Overall (n = 1770)

Class I (n = 878)

Class II (n = 114)

Class III (n = 106)

Class IV (n = 672)

P

13.3
6.8
9.4
1.3
3.2
8.4
3.1
3.1
31.0
11.5
9.0
3.2 (0.6)
38.7 (1.9)

26.5
13.3
18.7
1.8
6.3
16.9
0
5.4
0
0
11.2
3.2 (0.7)
38.8 (2.1)

1.8
3.5
0
0
0
0
47.4
5.3
0
0
42.1
3.2 (0.6)
38.9 (1.8)

0
0
1.9
6.6
0.9
0
0
0.9
0
76.4
13.2
3.1 (0.6)
38.4 (1.7)

0
0
0
0
0
0
0.2
0
81.7
18.2
0
3.3 (0.5)
38.5 (1.5)

84.0
7.6
8.4
7.7
38.5

83.7
5.6
10.7
4.9
40.1

82.5
9.6
7.9
2.6
44.7

76.4
13.2
10.4
10.5
36.8

85.9
9.1
5.1
11.9
35.6

11.3
24.4
38.8
8.3
17.2

11.9
26.3
38.7
8.5
14.6

11.4
28.9
33.3
9.6
16.7

9.4
5.7
34.0
3.8
47.2

10.9
24.1
40.5
8.5
16.1

85.1
6.6
8.3
38.5
35.2
71.9

86.9
2.9
10.3
16.1
28.6
53.1

69.3
6.1
24.6
28.4
39.5
80.7

93.4
1.9
4.7
49.2
41.4
53.8

84.2
12.2
3.6
70.0
55.1
97.8

—
—
—
—
—
—
—
—
—
—
—
—
.10
,.001
,.001
—
—
—
,.001
.15
,.001
—
—
—
—
—
,.001
—
—
—
,.001
,.001
,.001

14.5 (3.7)

14.4 (3.9)

15.6 (5.2)

14.3 (4.0)

14.6 (3.1)

,.001

77.6 (18.8)
63.5
36.8
88.2 (16.7)
36.1
15.3

80.6 (18.3)
57.7
30.0
88.3 (16.1)
34.8
13.8

79.2 (20.3)
62.9
31.4
86.0 (17.3)
40.4
20.2

76.3 (17.8)
73.8
36.9
90.5 (14.8)
26.4
12.3

73.7 (18.7)
69.4
46.4
88.0 (17.6)
38.7
17.0

,.001
,.001
,.001
.24
.05
.12

Values are expressed as % or mean (SD). Missing ,10% of sample except prenatal diagnosis (n = 1541) and preoperative mechanical ventilation (n = 1305). P values were determined by
x 2 tests for categorical variables and Kruskal–Wallis tests for continuous variables except the BSID measures, for which analysis of variance was used. Class I, 2 ventricles with no aortic
arch obstruction; Class II, 2 ventricles with aortic arch obstruction; Class III, single ventricle with no arch obstruction; and Class IV, single ventricle with arch obstruction. AVC,
atrioventricular canal; IAA, interrupted aortic arch; TAPVC, total anomalous pulmonary venous connection.

(foundation models; see Table 2)
were performed to determine
additional independent predictors of
neurodevelopmental outcome, as well
as to examine temporal trends when
considering all measured potential
risk factors. Later year of birth was
not signiﬁcantly associated with
better PDI or MDI when adjusting for
center and cardiac class.
Independent predictors of lower PDI
included lower birth weight, white
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race, and presence of a deﬁnite or
suspected genetic or extracardiac
anomaly (full model in Table 2). The
ﬁnal model for PDI included 1675
subjects from 22 centers with an
adjusted R2 of 24.3% and root mean
square error of 16.2. A statistically
signiﬁcant annual improvement in
PDI (0.39 points/year, 95%
conﬁdence interval [CI] 0.01 to 0.78;
P = .045) was observed in the fully
adjusted model.

Independent predictors of lower MDI
included lower birth weight, male
gender, less maternal education, and
presence of a deﬁnite or suspected
genetic or extracardiac anomaly (full
model in Table 2). The ﬁnal model for
MDI included 1717 subjects from
22 centers with an adjusted R2 of
27.7% and root mean square error
of 14.2. A statistically signiﬁcant
annual improvement in MDI
(0.38 points/year, 95% conﬁdence
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use this unique dataset to determine
whether improvements in
neurodevelopmental performance
mirrored those of survival.

FIGURE 1
A, Distribution of cardiac class in study cohort by year of birth. Class I, 2 ventricles with no aortic
arch obstruction; Class II, 2 ventricles with aortic arch obstruction; Class III, single ventricle with no
arch obstruction; and Class IV, single ventricle with arch obstruction. B, Distribution of deﬁnite or
suspected genetic or major extracardiac anomalies by year of birth.

interval 0.05 to 0.71; P = .02) was
observed in the fully adjusted model.
Interestingly, gestational age, prenatal
diagnosis, and neonatal status were
not signiﬁcantly associated with
PDI or MDI after adjustment for the
other variables in the full models.
A graphical presentation of the
standardized mean PDIs and MDIs
based on a model using year of birth
categories and continuous year of
birth with the corresponding ﬁnal set
of independent predictors is provided
in Fig 2. In addition, relationships of
PDIs and MDIs with the corresponding
ﬁnal set of independent predictors
were examined for the homogeneous
diagnostic subgroups (Table 3),
including adjustment for VSD in TGA
patients and adjustment for PA in TOF
patients. After adjustment for patient
factors, an annual improvement in
scores was identiﬁed only in the TOF
group.
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DISCUSSION
The past 2 decades have seen
dramatic improvements in survival of
infants with complex CHD due to
advances in surgical and
perioperative care and
management.26 Concomitant with
diminishing early mortality rates,
neurodevelopmental disabilities have
been increasingly recognized in
a substantial proportion of survivors.
In this project, we aggregated
individual participant patient factors
and neurodevelopmental outcome
data, measured with the same
instrument, from existing studies to
create the largest cohort (.1700
subjects) reported to date. The use of
individual participant data provides
the opportunity for extensive data
review, allows the inclusion of
unpublished data to reduce
publication bias, and enables further
subgroup analyses.12 We sought to

Mean PDIs and MDIs were lower than
expected compared with the general
population. In unadjusted analyses,
improvements over time were not
evident in either motor function (PDI)
or cognitive function (MDI). The
composition of the cohort changed
over the study, with an increasing
number of patients with more
complex CHD in the later years, likely
affecting temporal trends.
Nonetheless, we could not identify
signiﬁcant improvements in outcomes
over time, even when restricting
unadjusted analyses to homogeneous
diagnostic subgroups of TGA, TOF, and
HLHS. Similarly, in analyses adjusting
for center and complexity of CHD
(ie, foundation models), we did not
ﬁnd improvement in either PDI or MDI
over the study period. In contrast, in
multivariable analyses for the whole
cohort, incorporating patient and
preoperative medical risk factors,
performance for both PDI and MDI
showed statistically signiﬁcant
improvements, albeit of modest
magnitude. Interestingly, in
multivariable analyses for the
diagnostic subgroups, performance
improved only for the TOF patients,
but not for the TGA or HLHS groups.
The absence of improved scores over
time in unadjusted analyses or
foundation models, but increasing
scores in multivariable analyses,
suggests that more patients at greater
risk for adverse neurodevelopmental
outcomes are undergoing congenital
heart surgery and/or that high-risk
patients are more often surviving.
There are several potential
explanations for this ﬁnding. Patient
and environmental factors, such as
prematurity, genetic syndromes, and
socioeconomic status, may be more
important determinants of
neurodevelopmental outcomes than
are operative management
strategies.7,9,24 Brain development is
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TABLE 2 Multivariable Linear Regression of Psychomotor and Mental Development Index With Patient Risk Factors
Variable

PDI
Foundation Model

Patients (centers), n
Adjusted R 2, %
Root MSE
Year of birth
b-estimate (P)
95% CI
Center, P
Cardiac class, P
I
II
b-estimate (P)
95% CI
III
b-estimate (P)
95% CI
IV
b-estimate (P)
95% CI
Birth weight (per kg)
b-estimate (P)
95% CI
Race, P
White
Black
b-estimate (P)
95% CI
Other
b-estimate (P)
95% CI
Female gender
b-estimate (P)
95% CI
Maternal education, P
Graduate school
Completed college
b-estimate (P)
95% CI
High school and/or some college
b-estimate (P)
95% CI
Less than high school
b-estimate (P)
95% CI
Missing or not speciﬁed
b-estimate (P)
95% CI
Genetic anomaly, P
Normal or not speciﬁed
Suspected genetic or major extracardiac
b-estimate (P)
95% CI
Deﬁnite genetic
b-estimate (P)
95% CI

1725 (23)
13.3
17.5

MDI
Full Model

Foundation Model

Full Model

1675 (22)
24.3
16.2

1768 (23)
10.0
15.8

1717 (22)
27.7
14.2

0.31 (.14)
20.10 to 0.72
,.001
,.001
Reference

0.39 (.045)
0.01 to 0.78
,.001
,.001
Reference

0.27 (.15)
20.10 to 0.63
,.001
.002
Reference

0.38 (.02)
0.05 to 0.71
,.001
,.001
Reference

20.6 (.77)
24.2 to 3.1

1.5 (.39)
21.9 to 5.0

20.9 (.58)
24.1 to 2.3

1.3 (.39)
21.6 to 4.2

25.3 (.006)
29.1 to 21.5

26.1 (.001)
29.7 to 22.4

20.2 (.90)
23.6 to 3.2

0.03 (.99)
23.1 to 3.2

210.7 (,.001)
213.1 to 28.3

211.4 (,.001)
213.6 to 29.1

24.1 (,.001)
26.3 to 21.9

24.9 (,.001)
26.8 to 22.9

—
—

—
—

4.38 (,.001)
3.22 to 5.54

—

3.21 (,.001)
1.86 to 4.55
(.01)
Reference

—

—

—
—

4.6 (.003)
1.5 to 7.7

—
—

—
—

—
—

1.4 (.36)
21.6 to 4.4

—
—

—
—

—
—

—
—

—
—

—

—

—

—
—

—
—

—
—

21.4 (.26)
23.8 to 1.0

—
—

—
—

—
—

24.7 (,.001)
27.0 to 22.4

—
—

—
—

—
—

26.8 (,.001)
29.9 to 23.6

—
—
—
—

—
—
,.001
Reference

—
—
—
—

24.8 (.003)
27.9 to 21.6
,.001
Reference

—
—

28.3 (,.001)
211.5 to 25.1

—
—

28.3 (,.001)
211.1 to 25.4

—
—

219.9 (,.001)
222.9 to 216.9

—
—

220.8 (,.001)
223.4 to 218.2

2.4 (,.001)
1.0 to 3.8
,.001
Reference

All characteristics from Table 1 except preoperative mechanical ventilation were considered for inclusion in the models. Coefﬁcients for intercepts and center indicator variables are not reported. MSE,
mean square error, with root MSE representing the sample SD of the differences between observed and predicted values. CI, conﬁdence interval. —, variable not included in the corresponding model.

abnormal in children with CHD.
Magnetic resonance imaging (MRI)
studies in CHD fetuses show smaller
total brain volumes (adjusted for
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gestational age and weight) and
abnormal brain metabolism, as well
as delayed cortical development and
folding.27–31 At birth, brain

maturation in neonates with HLHS or
TGA is delayed by ∼1 month
compared with a normative sample.29
Postnatal MRI studies have shown
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FIGURE 2
Standardized PDI and MDI means by year of birth. The standardized means plot the predicted PDIs
and MDIs and SE bars based on a model with year of birth category adjusting for center, cardiac
class, and other statistically signiﬁcant predictors at the mean value of the covariates. Overlaid are
standardized means plots based on continuous year of birth. The horizontal dotted line represents
the normative mean of 100 for both PDI and MDI.

that white matter injury is evident in 1
of 5 infants before cardiac
surgery.32–34 Andropoulos et al
showed that a lower brain maturity
score at birth by MRI is associated
with greater brain injury in both the
preoperative and postoperative
periods.33 Beca et al recently reported
that severity of brain immaturity at
birth predicts the severity of
neurodevelopmental impairment at
2 years of age after cardiac surgery in
infancy.34 In addition, von Rhein et al
showed that brain volumes remain
smaller into adolescence and that the
magnitude of reduction correlates
with neurodevelopmental outcomes.35
Thus, altered brain development due
to CHD may increase vulnerability to
perioperative hemodynamic instability
and intraoperative brain injury due to
hypoxia and ischemia. The lack of
greater improvement in early
neurodevelopmental outcomes over
the study period, despite
contemporaneous improvements in
survival, surgical strategies, and
perioperative care, thus may be due to
the greater effects of innate patient
factors and abnormal brain
maturation, which outweigh the
impact of modiﬁable management
factors in determining
neurodevelopmental outcomes of
children with CHD.
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In the latter years of the study period,
a greater percentage of subjects had
deﬁnite genetic anomalies. Several
factors may explain this ﬁnding. Many
of the early developmental studies in
cardiac patients speciﬁcally excluded
those with identiﬁed genetic
syndromes. Additionally, genetic
testing has become more prevalent in
recent years and is a routine
component of clinical care of complex
CHD in many clinical centers. Finally,
methods of discerning genetic
anomalies have become increasingly
sensitive, improving the yield of
testing and potentially exposing
abnormal genetic underpinnings to
CHD that escape recognition on
physical examination by subspecialists
in genetics. For example, a recent
study showed pathogenic copy
number variants in $10% of children
with single ventricle lesions, only
a minority of whom were noted to be
dysmorphic on examination by
a clinical geneticist.36 If genetic
anomalies were ascertained more
frequently over time in our dataset,
adjustment for genetic anomalies may
have caused us to overestimate the
improvement in outcomes over time.
There are limitations to this analysis.
This study is not a formal
metaanalysis. To develop as large
a dataset as possible, investigators

were asked to submit both published
and unpublished data from their
institutions. We did not formally
assess the quality of study design and
execution for each study. The trends in
scores were examined over a relatively
brief time interval of 14 years, during
which the BSID-II was the
standardized neurodevelopment test
of choice at many centers. The earliest
enrolled patients in our study
postdated some important changes in
the management of cardiopulmonary
bypass for infants. Our analyses did
not consider subsequent changes in
intraoperative management strategies.
We cannot exclude the possibility
that improvement in MDI in the
multivariable analyses may be
the result of the Flynn effect, ie, the
ﬁnding that, in the general population,
cognitive function assessed by
neurodevelopmental test scores
improves over time by 0.3 to 0.5
points per year or ∼5 points per
decade.37 In addition, early
neurodevelopmental testing has
limited predictive value for later
neurodevelopmental outcomes.38,39
Finally, the data are assembled from
existing data sets of multiple studies.
Some studies were clinical trials and
others were observational studies. The
study designs and goals, inclusion and
exclusion criteria, and data collected
varied considerably. Furthermore,
characteristics of the subjects in the
combined dataset, such as diagnosis
and surgical class, changed over the
study period. Subjects in later years
had greater disease severity and were
more likely to have an identiﬁed
genetic syndrome. All of these factors
may limit generalizability of the study
inferences. However, the strengths of
this analysis relate to the substantial
sample size, and the ﬁndings
represent the consolidation of nearly
all published information concerning
early neurodevelopmental outcomes
in this population.

CONCLUSIONS
In this analysis of pooled individual
participant data, early
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TABLE 3 Multivariable Linear Regression of Psychomotor and Mental Development Index With Patient Risk Factors for Select Homogeneous Diagnostic
Subgroups
Variable

TGA
PDI

Patients (centers), n
Adjusted R 2, %
Root MSE
Year of birth
b-estimate (P)
95% CI
Center, P
Cardiac subclass
Intact ventricular septuma
b-estimate (P)
95% CI
No pulmonary atresiab
b-estimate (P)
95% CI
Birth weight (per kg)
b-estimate (P)
95% CI
Race, P
White
Black
b-estimate (P)
95% CI
Other
b-estimate (P)
95% CI
Female gender
b-estimate (P)
95% CI
Maternal education, P
Graduate school
Completed college
b-estimate (P)
95% CI
High school and/or some college
b-estimate (P)
95% CI
Less than high school
b-estimate (P)
95% CI
Missing or not speciﬁed
b-estimate (P)
95% CI
Genetic anomaly, P
Normal or not speciﬁed
Suspected genetic or major extracardiac
b-estimate (P)
95% CI
Deﬁnite genetic
b-estimate (P)
95% CI

324 (9)
13.6
14.6

TOF

HLHS

MDI

PDI

MDI

334 (9)
22.9
12.2

174 (8)
33.6
15.1

179 (8)
37.4
12.5

PDI

MDI

541 (20)
11.5
17.5

549 (20)
20.3
15.6

0.07 (.87)
20.76 to 0.90
,.001

0.33 (.35)
20.36 to 1.03
,.001

1.43 (.04)
0.07 to 2.79
.01

1.12 (.0497)
0.002 to 2.25
,.001

0.48 (.19)
20.23 to 1.20
,.001

20.11 (.73)
20.74 to 0.51
,.001

3.6 (.04)
0.1 to 7.1

20.8 (.59)
23.7 to 2.1

—
—

—
—

—
—

—
—

—
—

—
—

9.2 (.01)
2.1 to 16.4

3.5 (.24)
22.4 to 9.4

—
—

—
—

2.73 (.07)
20.17 to 5.63
.37
Reference

3.30 (.007)
0.89 to 5.70
—

2.77 (.13)
20.84 to 6.38
.35
Reference

4.24 (.006)
1.26 to 7.22
—

2.51 (.09)
20.40 to 5.42
.03
Reference

4.64 (,.001)
2.05 to 7.24
—

25.0 (.32)
214.8 to 4.9

—
—

2.1 (.72)
29.6 to 13.7

—
—

4.8 (.10)
20.9 to 10.5

—
—

2.6 (.34)
22.8 to 8.0

—
—

5.9 (.15)
22.2 to 14.1

—
—

27.3 (.05)
214.7 to 0.1

—
—

—
—
—
—

1.1 (.58)
22.9 to 5.1
.049
Reference

—
—
—
—

2.6 (.07)
25.5 to 0.2
.006
Reference

—
—
—
—

6.4 (,.001)
3.5 to 9.3
,.001
Reference

—
—

23.4 (.19)
28.6 to 1.7

—
—

6.0 (.03)
0.5 to 11.5

—
—

21.7 (.48)
26.6 to 3.1

—
—

29.4 (,.001)
214.3 to 24.4

—
—

3.0 (.27)
22.3 to 8.3

—
—

26.2 (.007)
210.8 to 21.7

—
—

213.1 (,.001)
219.2 to 26.9

—
—

2.3 (.61)
26.6 to 11.3

—
—

27.9 (.02)
214.3 to 21.5

—
—
.01
Reference

26.8 (.03)
213.0 to 20.5
,.001
Reference

—
—
,.001
Reference

213.0 (.10)
228.5 to 2.5
,.001
Reference

—
—
,.001
Reference

26.8 (.02)
212.5 to 21.1
,.001
Reference

216.8 (.03)
231.7 to 22.0

213.8 (.03)
226.2 to 21.4

218.6 (.005)
231.4 to 25.8

222.4 (,.001)
233.1 to 211.6

27.9 (,.001)
212.6 to 23.3

26.8 (.001)
210.9 to 22.7

223.2 (.03)
244.2 to 22.3

228.3 (,.001)
242.6 to 214.1

222.6 (,.001)
229.8 to 215.5

220.3 (,.001)
225.9 to 214.6

218.5 (,.001)
227.4 to 29.5

221.5 (,.001)
229.2 to 213.7

CI, conﬁdence interval; MSE, mean square error, with root MSE representing the sample SD of the differences between observed and predicted values. —, variable not included in the
corresponding model.
a In comparison with ventricular septal defect.
b In comparison with pulmonary atresia.

neurodevelopmental outcomes after
cardiac surgery in newborns and
infants are below population means
and, even after adjustment for center
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and class, have not signiﬁcantly
improved in recent years. After
adjustment for patient and
preoperative medical factors,

however, both PDI and MDI improved
signiﬁcantly by a modest degree
(∼5–6 points over 14 years).
Multivariable regression analyses
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showed that patient factors (race,
gender, birth weight, genetic
anomalies, type of CHD, and maternal
education) are important

determinants of neurodevelopmental
outcomes. To the extent that subjects
in this study reﬂect true temporal
trends, these data suggest that more

high-risk CHD infants are undergoing
cardiac surgery and surviving, creating
a growing population that will require
signiﬁcant societal resources.
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SUPPLEMENTAL TABLE 5 Patient and Demographic Factors
Variable
Cardiac class

Cardiac diagnosis

Year of birth
Birth weight
Gestational age
Race

Ethnicity
Gender
Maternal education

Genetic or nongenetic anomaly

Description of genetic or major
extracardiac anomaly

Prenatal diagnosis
Preoperative mechanical ventilation

Deﬁnition
Class I: Two ventricle/no arch obstruction
Class II: Two ventricle/arch obstruction
Class III: Single ventricle/no arch obstruction
Class IV: Single ventricle/arch obstruction
d-Transposition of the great arteries with intact ventricular
septum
d-Transposition of the great arteries with ventricular septal
defect
Tetralogy of Fallot
Tetralogy of Fallot with pulmonary atresia
Truncus arteriosus
Total anomalous pulmonary venous connection
Ventricular septal defect without interrupted aortic arch and
coarctation
Ventricular septal defect with interrupted aortic arch and
coarctation
Coarctation and arch hypoplasia
Atrioventricular canal defects (partial, transitional, or complete)
Pulmonary atresia with intact ventricular septum
Hypoplastic left heart syndrome
Other functional single ventricle anomaly
Other cardiac diagnosis
Kilograms
Weeks
White
Black/African American
Other
Hispanic/Non-Hispanic
Female/male
Graduate school
Completed college
High school and/or some college
Less than high school
Missing or not speciﬁed
Normal or anomaly not speciﬁed
Suspected genetic or nongenetic anomaly
Deﬁnite genetic anomaly
Alagille syndrome
CHARGE (coloboma, heart defect, atresia choanae, retarded
growth and development, genital abnormality, and ear
abnormality)
22q11 deletions
Goldenhar syndrome
Holt–Oram syndrome
Jacobsen syndrome
Kabuki syndrome
Noonan’s syndrome
Trisomy 13
Trisomy 18
Trisomy 21
Turner’s syndrome
VATER/VACTERL (vertebrae, imperforate anus or anal atresia,
cardiac anomalies, tracheoesophageal ﬁstula, renal
anomalies, limb anomalies)
Williams syndrome
Multiple congenital anomalies, not otherwise speciﬁed
Fetal alcohol spectrum disorder
Abnormality of genetic testing not otherwise speciﬁed
Other genetic or major extracardiac anomaly
Yes/no
Yes/no, if on mechanical ventilation when taken to operating room
for surgery
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